Wittawat Chantkran

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Cross Sectional

Hypertensive Patients

Affordable Care Act

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cell death discovery

Journal of clinical laboratory analysis

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Dollapak Apipongrat, Pornnapa Police, Rattapan Lamool, Punnee Butthep, Wittawat Chantkran
Validation of high concentrated thrombin time assay for unfractionated heparin monitoring. Journal of clinical laboratory analysis 36 (10) (2022)
Wittawat Chantkran, Ya-Ching Hsieh, Daniella Zheleva, Sheelagh Frame, Helen Wheadon, Mhairi Copland
Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML. Cell death discovery 7 (1) (2021)
Wittawat Chantkran, Ya-Ching Hsieh, Daniella Zheleva, Sheelagh Frame, Helen Wheadon, Mhairi Copland
Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML. Cell death discovery 7 (1) (2021)
Wittawat Chantkran, Janeyuth Chaisakul, Ram Rangsin, Mathirut Mungthin, Boonsub Sakboonyarat
Prevalence of and factors associated with stroke in hypertensive patients in Thailand from 2014 to 2018: A nationwide cross-sectional study. Scientific reports 11 (1) (2021)
Wittawat Chantkran, Pitipat Jamnarnwej, Pipat Sritanabutr, Pasra Arnutti
Evaluation of point-of-care testing device for anemia detection: A cross-sectional method comparison study from Thailand. Journal of clinical laboratory analysis 35 (10) (2021)